Toggle Main Menu Toggle Search

Open Access padlockePrints

Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunity

Lookup NU author(s): Dr Christopher DuncanORCiD, Dr Rebecca PayneORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2025. The Author(s). COVID-19 vaccines were updated to address immune escape from variants of concern (VOC). We explored the impact of ancestral/BA.1 bivalent mRNA booster vaccination (Autumn 2022) on peripheral and nasal antibody and T-cell responses to SARS-CoV-2 in an observational cohort of 133 healthcare workers, building on previous longitudinal vaccination studies. We demonstrate that maintenance of antibody and T-cell responses up to eighteen months following the third vaccine is at least partially driven by intercurrent infection. Boosting with the bivalent vaccine increases the breadth of circulating and nasal antibodies to spike, which waned over time but was still detectable six months post-dose. T-cell responses are well maintained and highly cross-reactive to VOCs irrespective of booster vaccination. Vaccination strongly boosted nasal IgG, but this was short-lived compared to circulating antibodies. Overall, ongoing COVID-19 vaccination provides benefit, boosting immunity in individuals who have not been recently infected, but new strategies may be needed to provide longer-term nasal immunity.


Publication metadata

Author(s): Kronsteiner B, Govender M, Liu C, Dijokaite-Guraliuc A, Ali M, Hill J, Zewdie M, Cross A, Austin J, Watts A, Angyal A, Hornsby H, Abraham P, Adele S, Moulik S, Harte J, Hargreaves A, Jiwa Y, Selvaraj M, Stafford L, Jamsen A, Dobson SL, Sampaio S, Halstead C, Steel A, Longet S, Faustini SE, Moore SC, Mongkolsapaya J, Wootton DG, Thaventhiran JED, Hopkins S, Hall V, Jeffery K, Barnes E, Duncan CJA, Payne RP, Richter AG, de Silva TI, Turtle L, Screaton GR, Klenerman P, Carroll M, Dunachie SJ

Publication type: Article

Publication status: Published

Journal: Scientific Reports

Year: 2025

Volume: 15

Online publication date: 27/11/2025

Acceptance date: 10/11/2025

Date deposited: 12/01/2026

ISSN (electronic): 2045-2322

Publisher: Springer Nature

URL: https://doi.org/10.1038/s41598-025-28310-0

DOI: 10.1038/s41598-025-28310-0

Data Access Statement: The de-identified experimental data that support the findings of this study are available on Mendeley Data under https://data.mendeley.com/datasets/7h2wwgnk3p/1

PubMed id: 41310059


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
204721/Z/16/ZWellcome Trust
211153/Z/18/ZWellcome Trust
Huo Family Foundation
MRC Clinician Scientist Fellowship (MR/X001598/1)
NIHR (UKRIDHSC COVID-19 Rapid Response Rolling Call, Grant Reference Number COV19-RECPLAS)
UK Department of Health and Social Care
UKRI "Investigation of proven vaccine breakthrough by SARS-CoV-2 variants in established UK healthcare worker cohorts: SIREN consortium & PITCH Plus Pathway" MR/W02067X/1
UKRI "PITCH2—Protective Immunity through T Cells in Healthcare workers 2" MR/X009297/1
UKRI/NIHR through the UK Coronavirus Immunology Consortium (UK-CIC)

Share